Johns Hopkins University Carey Business School

Public Favors Compensation For Kidney Donors If Payments Portend Big Boost in Transplants and Organs Allocated Fairly; Pilot Studies Would Be Useful

Newswise — Nearly a fifth of the respondents in a recent study said they would reverse their opposition to compensating kidney donors if a form of non-cash payment led to a substantial increase in the supply of available organs for transplant. “This group is essentially saying, ‘I don’t like giving compensation to kidney donors, but if you tell me it can save a lot of lives, then I’m for it,’” explains researcher Mario Macis of the Johns Hopkins Carey Business School, describing the opinion shift expressed by 18 percent of the study participants.

The paper co-authored by Macis and two colleagues, “Paying for Kidneys? A Randomized Survey and Choice Experiment,” is forthcoming in the American Economic Review.

The issue at the heart of the research is literally a life-and-death matter. As the article notes, about 95,000 Americans are waiting for kidney transplants. The average wait is 4½ years, and several thousands of people die each year while on the list of candidates.

On July 10, President Trump issued an executive order aimed at educating and treating people with early forms of kidney disease, easing the process for obtaining a kidney transplant, and expanding financial assistance for living donors.

Paying people to donate organs is illegal in the United States and virtually every other nation. Drawing on data from a randomized survey of about 3,000 Americans, Macis and his colleagues aimed to determine to what extent the American public would support or oppose compensating kidney donors. A key underlying goal of the researchers was to provide evidence that policy makers might use when considering whether donor-compensation initiatives might gain broad public acceptance.

Macis, an associate professor of economics at the Carey Business School, says three main findings emerged:

  • Americans’ attitudes toward paying kidney donors are polarized. Forty-six percent of respondents said they favor compensating donors whether or not it markedly increased the supply of available organs. Of those who opposed compensation, 21 percent said they did so regardless of the impact on organ supply. “They were against it, even if it meant satisfying the total demand for organs,” says Macis. “They have a ‘sacred value,’ an absolute moral imperative that opposes compensation, while the 46 percent favor it because they see an element of fairness in compensating donors for an act that demands a lot from them.
  • About a fifth, 18 percent, said they would change from opposing to supporting compensation if it meant a significant boost in the supply of organs. “This is consistent with utilitarian preferences,” Macis says. “They’re willing to make that trade-off, from no to yes, if they see it can do a lot of good for people awaiting transplants. Thus, a majority would favor compensation for kidney donors if it resulted in enough additional lives saved”
  • Sentiment was strong against the idea of a private market for organs, in which individual donors and patients would deal directly with each other. “People in our study did not like the idea of a free-market solution,” says Macis. “They didn’t want a Craig’s List for organs. However, respondents would like to see a system in which a government agency oversees both the compensation for organ donations and the distribution of organs to patients. This could be non-cash payments, like forgiveness of loan debt or a deposit into a retirement fund. According to this finding, we shouldn’t even be talking about private markets for kidneys and other organs, and policymakers would be smart to avoid that approach.”

Rep. Matt Cartwright, a Pennsylvania Democrat, has sponsored a bill in the U.S. House of Representatives that would clarify what types of compensation might be permissible under the federal National Organ Transplant Act of 1984, which prohibits the buying or selling of human organs for “valuable consideration.” The bill also would promote the creation of pilot studies to test the impact of non-cash compensation on the organ supply.

Macis and his colleagues – fellow economists Professor Julio Elias of Universidad del CEMA in Buenos Aires and Associate Professor Nicola Lacetera of the University of Toronto – have no connection to Cartwright or his proposed legislation. But Macis says he is glad to see the congressman’s call for further study.

“We need more evidence so policymakers can see what is and what isn’t viable where compensation for organ donors is concerned,” says Macis. “It’s the kind of information that would be critical if, for example, a ballot initiative on this question were to be considered.”

Filters close

Showing results

110 of 4581
Newswise: Lockdown affords Aussie tennis players a unique advantage
Released: 18-Jan-2021 10:05 PM EST
Lockdown affords Aussie tennis players a unique advantage
University of South Australia

Australian-based tennis players may have a once-in-a-lifetime court advantage at the 2021 Australian Open as many of their international counterparts endure lockdown restrictions in Melbourne hotels.

access_time Embargo lifts in 2 days
Embargo will expire: 21-Jan-2021 12:00 AM EST Released to reporters: 18-Jan-2021 8:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 21-Jan-2021 12:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Jan-2021 5:05 PM EST
FLCCC Alliance issues public response to new NIH recommendation on the use of ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

The Front Line COVID-19 Critical Care Alliance (FLCCC) has issued a public response to the National Institutes of Health (NIH) regarding the NIH COVID-19 Treatment Guidelines Panel’s “neither for nor against” recommendation for the use of ivermectin in the treatment of COVID-19.

Newswise: UCLA Researcher’s Team Finds Common Blood Pressure Medications do not Increase COVID-19 Risk
Released: 18-Jan-2021 12:05 PM EST
UCLA Researcher’s Team Finds Common Blood Pressure Medications do not Increase COVID-19 Risk
UCLA Fielding School of Public Health

Dr. Marc Suchard, of the UCLA Fielding School of Public Health, co-led international research team looking at two widely used types of blood pressure drugs.

Newswise: UCLA Fielding School of Public Health Researchers Say Mask Mandates Could add $1 Trillion to the U.S. GDP
Released: 18-Jan-2021 12:05 PM EST
UCLA Fielding School of Public Health Researchers Say Mask Mandates Could add $1 Trillion to the U.S. GDP
UCLA Fielding School of Public Health

The team, including UCLA Fielding School of Public Health professors Anne Rimoin and Christina Ramirez, found that near-universal adoption of nonmedical masks in public, combined with complementary public health measures, could successfully eliminate spread of the infection. and add $1 Trillion to the U.S. GDP.

Released: 18-Jan-2021 10:45 AM EST
Mount Sinai Researchers Build Models Using Machine Learning Technique to Enhance Predictions of COVID-19 Outcomes
Mount Sinai Health System

Mount Sinai researchers have published one of the first studies using federated learning to examine electronic health records to better predict how COVID-19 patients will progress.

Newswise:Video Embedded pregnant-women-should-consider-taking-the-covid-19-vaccine
Released: 18-Jan-2021 7:50 AM EST
Pregnant women should consider taking the COVID-19 vaccine.
University of Washington School of Medicine

f pregnant individuals catch COVID they will generally get sicker than non-pregnant individuals. They also more commonly end up on ECMO [heart-lung support], in the ICU or on ventilators.

Newswise: Have allergies? Worried about COVID-19 vaccine? Don’t be.
Released: 18-Jan-2021 7:40 AM EST
Have allergies? Worried about COVID-19 vaccine? Don’t be.
UW Medicine

Even people who have experienced severe allergic reactions to food, latex, pets, pollen, or bee stings should get the coronavirus vaccine, UW Medicine allergy and infectious disease experts say.

Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Showing results

110 of 4581